Asenapine versus olanzapine in acute mania: a double-blind extension study.
about
Effects of asenapine on depressive symptoms in patients with bipolar I disorder experiencing acute manic or mixed episodes: a post hoc analysis of two 3-week clinical trialsEfficacy of antimanic treatments: meta-analysis of randomized, controlled trialsA critical appraisal of treatments for bipolar disorderEvaluation of the clinical efficacy of asenapine in schizophreniaAsenapine for bipolar disorderA review of the pharmacology, efficacy and tolerability of recently approved and upcoming oral antipsychotics: an evidence-based medicine approach.Predictive animal models of mania: hits, misses and future directions.Asenapine: a review of acute and extension phase data in bipolar disorder.Quantification of asenapine and three metabolites in human plasma using liquid chromatography-tandem mass spectrometry with automated solid-phase extraction: application to a phase I clinical trial with asenapine in healthy male subjects.Cost-effectiveness of asenapine in the treatment of patients with bipolar I disorder with mixed episodes in an Italian context.Weight gain, obesity, and psychotropic prescribing.The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder.Review of the safety, efficacy, and side effect profile of asenapine in the treatment of bipolar 1 disorder.Pharmacological treatment of mixed states.Asenapine in bipolar I disorder: evidence and place in patient management.Asenapine in the treatment of older adults with bipolar disorderAsenapine augmentation in bipolar disorders: a case series.New approaches for the management of bipolar disorder: role of sublingual asenapine in the treatment of mania.Cost-effectiveness of asenapine in the treatment of bipolar disorder in CanadaDoes the efficacy of asenapine in bipolar disorder increase in the presence of comorbidity with a substance use disorder? A naturalistic study.A Guide to Medications Inducing Salivary Gland Dysfunction, Xerostomia, and Subjective Sialorrhea: A Systematic Review Sponsored by the World Workshop on Oral Medicine VI.Pharmacology and efficacy of asenapine for manic and mixed states in adults with bipolar disorder.Asenapine: a review of its use in the management of mania in adults with bipolar I disorder.Obesity and psychotropics.Olanzapine-induced weight gain in patients with bipolar I disorder: a meta-analysis.Efficacy of antimanic treatments in mixed states.Comparing tolerability of olanzapine in schizophrenia and affective disorders: a meta-analysis.Asenapine for the treatment of manic and mixed episodes associated with bipolar I disorder: from clinical research to clinical practice.Oral antipsychotic update: a brief review of new and investigational agents for the treatment of schizophrenia.Use of asenapine in clinical practice for the management of bipolar mania.Receptor mechanisms of antipsychotic drug action in bipolar disorder - focus on asenapineAsenapine review, part II: clinical efficacy, safety and tolerability.Clinical decision making in the treatment of mixed states.Preliminary examination of microRNA expression profiling in bipolar disorder I patients during antipsychotic treatment.World Workshop on Oral Medicine VI: a systematic review of medication-induced salivary gland dysfunction.Treating mixed mania/hypomania: a review and synthesis of the evidence.The role of asenapine in the treatment of manic or mixed states associated with bipolar I disorderComparison of somnolence associated with asenapine, olanzapine, risperidone, and haloperidol relative to placebo in patients with schizophrenia or bipolar disorder.Stability-indicating liquid chromatographic method for the quantification of the new antipsychotic agent asenapine in bulk and in pharmaceutical formulation.Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013.
P2860
Q21260328-6F9974B7-8408-4A71-BCB3-5D6D57A775BDQ24601815-D64E91EF-A54C-4F50-846F-4EAA22956FF5Q24613657-EDD301F6-1541-4509-8F9B-AB49A7AF4272Q24630385-C1A55D80-0CEA-4FA4-8DB6-6AE564A83D70Q26775399-E2885BD1-FA2B-4DDF-9274-521B0D5E3A4DQ30353864-66BF686B-DB2E-4DE9-9204-56D22D8D6B4EQ30462823-05E298BB-1040-41BD-9F43-C72785A36785Q33719794-C59D67AF-403E-44E2-BB35-E72248500C3FQ33894135-47F191DC-3E46-4D00-ACE3-8A92C6A1E3A5Q34100578-B427898A-2B34-4474-980C-C761CFBF89DCQ34557537-49CCC40D-3A15-476B-A8E9-9789E0910607Q34649187-40EE76AA-3766-45C7-8339-D60F1DBBF4D8Q35117888-465D5FCE-5838-4C95-A8B1-3A90E2DC4297Q36349023-27D0D92D-1195-4FC8-8742-6DF98E32F975Q36515504-643A2E17-6C62-4159-AA0E-0560973E483EQ36794665-04039CC7-7C4D-40A3-BF16-0F5952A73BD0Q36868401-E10C5E8E-612B-4C84-90A5-F98E702FE2B9Q36929705-52DD5A72-C33C-4642-9582-755BC211DDA5Q37528010-2AD759EB-C6E8-4D98-AABC-2B03D3D11064Q37649909-328C4DEF-D49B-4110-833C-DD6810B1DA67Q37653402-09BFF385-8941-449A-838C-E8C3C0125776Q37737289-48F61EC2-9DDB-42A5-8B08-B964324E62BAQ37842439-25BF5418-C904-48F4-AB38-023AF6BB666BQ37954390-6178E3F4-904B-4DDC-8B02-07698292B868Q37997775-4D306299-AA78-47C5-A5CC-5822D3BC97C2Q38003197-779D95B2-0CFC-43F5-A775-2F3C2A4CB891Q38042478-DE10FB8E-2EA7-40C7-ABD6-7D6B7E82830FQ38077281-CCF10FCA-0470-4A06-B7BB-038FEB9F7990Q38085441-1261E539-A37D-470F-851C-2C56AEC83144Q38093728-9ADEC08D-D2B4-4D7C-B4B3-277AB6E7FFD8Q38132163-4A7D70A9-DF7C-491E-A91E-A5B448AC4DD4Q38209081-6BC9B279-925A-4574-BD7E-E7E8F92C6D4DQ38211511-CC331C0E-3BC9-4A07-BAA0-AD21232BD387Q38447364-F4BD5E5F-6567-409B-A12F-F0D17513B96FQ38646237-C887BE9F-8498-481C-9EB7-2AE87FB70448Q39048607-2BD9EE62-4FA9-4F73-9587-C6CD6B01A41BQ41813300-4B1A60BE-ABDB-48CB-BF02-2BEFF3A05396Q41973696-9A0C43E2-4A28-4162-B617-8EA8B620851DQ42214706-E0971FE0-5AFA-4843-8BD0-40A95ED35F51Q44142664-4C4C117D-3BA5-4AD0-86F5-47EADA101555
P2860
Asenapine versus olanzapine in acute mania: a double-blind extension study.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Asenapine versus olanzapine in acute mania: a double-blind extension study.
@en
Asenapine versus olanzapine in acute mania: a double-blind extension study.
@nl
type
label
Asenapine versus olanzapine in acute mania: a double-blind extension study.
@en
Asenapine versus olanzapine in acute mania: a double-blind extension study.
@nl
prefLabel
Asenapine versus olanzapine in acute mania: a double-blind extension study.
@en
Asenapine versus olanzapine in acute mania: a double-blind extension study.
@nl
P2093
P1433
P1476
Asenapine versus olanzapine in acute mania: a double-blind extension study.
@en
P2093
John Panagides
Larry Alphs
Miriam Cohen
Roger S McIntyre
Thomas A Macek
P304
P356
10.1111/J.1399-5618.2009.00749.X
P577
2009-10-14T00:00:00Z